Pamela D. Garzone

Director at Cue Biopharma.

Raised on Cue Biopharma filings

$80M

of $80M offered across 2 Form D filings

Form D filings: 2
Teammates: 13
Last filing: Jul 22, 2026

Company

Biotech · Boston, MA

Biologics that modulate disease-specific T cells

Biologics that modulate disease-specific T cells

Investors: 118

Investors: 118
Sector: Biotech
HQ: Boston, MA

Cue Biopharma filings

Cue Biopharma Form D filings
Filed	Security	Sold of offered	Filing
Jul 22, 2026	Equity	$50M/ $50M	Form D
May 14, 2026	Security to be acquired	$30M/ $30M	Form D

EquityFiled Jul 22, 2026Form D
$50M/ $50M
Security to be acquiredFiled May 14, 2026Form D
$30M/ $30M

Works with

Also named on Cue Biopharma filings

Sumita Ray, JDChief Legal & Compliance Officer, Form D signerForm D signer Jill BroadfootDirector Michael MeluzioExecutive Officer Colin SandercockExecutive Officer Daniel BakerExecutive Officer Frank MorichDirector Patrick VerheyenDirector Peter KienerDirector Shao-Lee LinExecutive Officer, Director Daniel CamardoDirector Dominic BorieExecutive Officer Pasha SarrafDirector Viola MeehanDirector